Clinical and Instrumental Characteristics of Newly Diagnosed Patients with Various Forms of Pulmonary Hypertension according to the Russian National Registry

Table 3

Clinical symptoms in patients with PAH and CTEPH.

Clinical symptoms	Patient groups
	IPAH ()		PAH-CTD ()		PAH-CHD ()		PoPH ()		PAH group ()		CTEPH group ()
	Onset (, %)	Time of diagnosis verification (, %)	Onset (, %)	Time of diagnosis verification (, %)	Onset (, %)	Time of diagnosis verification (, %)	Onset (, %)	Time of diagnosis verification (, %)	Onset (, %)	Time of diagnosis verification (, %)	Onset (, %)	Time of diagnosis verification (, %)
Dyspnea	171 (85.9%)^2	197 (98.9%)	89 (94.7%)^4	92 (97.8%)	173 (97.2%)^4	178 (100%)	7 (77.8%)	9 (100%)	425 (87.3%)	483 (99.2%)	189 (91.7%)	202 (98.1%)
Fatigue	66 (33.1%)	129 (64.8%)^4	32 (34.0%)	72 (76.6%)	40 (22.5%)^4	122(68.5%)^4	5 (55.6%)	8 (88.9%)	242 (49.7%)	362 (74.3%)^#	63 (30.6%)	163 (79.1%)^#
Chest pain	34 (17.1%)	82 (41.2%)	12 (12.8%)^2	48 (51.2%)	39 (21.9%)^4	90 (50.6%)^4	1 (11.1%)	3 (33.3%)	72 (14.8%)	212 (43.5%)^#	70 (33.9%)	91 (44.2%)
Dizziness	45 (22.6%)^4	90 (45.2%)^4	22 (23.4%)^4	38 (40.4%)^4	41 (23.0%)^4	84 (47.2%)^4	1 (11.1%)	2 (22.2%)	75 (15.4%)	188 (38.6%)	21 (10.2%)	110 (53.4%)^#
Syncope	51 (25.6%)^4	55 (27.6%)^2.4	1 (1.1%)^1	11 (11.7%)^1.4	14 (7.9%)^4	22 (12.4%)^4	0 (0%)	0 (0%)	75 (15.4%)	125 (25.7%)	40 (19.4%)	25 (12.1%)
Palpitations	76 (38.2%)	128 (64.3%)^2	32 (34.0%)	78 (82.9%)^1	41 (23.0%)	80 (44.9%)^4	2 (22.2%)	7 (77.8%)	120 (24.6%)	312 (64.1%)^#	48 (23.3%)	106 (51.5%)^#
Cough	34 (17.1%)^4	80 (40.2%)^2.4	10 (10.6%)^4	46 (48.9%)^3.4	24 (13.5%)^4	60 (33.7%)	0 (0%)	3 (33.3%)	57 (11.7%)	187 (38.4%)	70 (33.9%)	123 (59.7%)^#
Hemoptysis	3 (1.5%)	4 (2.0%)	0 (0%)	0 (0%)	11 (6.2%)	39 (21.9%)^3.4	0 (0%)	0 (0%)	14 (2.9%)	28 (5.3%)	25 (12.1%)	50 (24.2%)
Hoarseness	0 (0%)	8 (4.0%)^4	0 (0%)	1 (1.1%)	0 (0%)	8 (4.5%)^4	0 (0%)	0 (0%)	0 (0%)	11 (2.3%)	0 (0%)	2 (0.9%)
Swelling of the legs/feet	30 (15.1%)	62 (31.2%)	15 (15.9%)	32 (34.0%)	22 (12.4%)	71 (39.9%)^4	1 (11.1%)	2 (22.2%)	60 (12.3%)	182 (37.4%)^#	46 (22.3%)	146 (68.4%)^#

vs. baseline; 1: ; 2: ; 3: ; 4: vs. PoPH .